Avadel Pharmaceuticals (AVDL) PT Slashed to $13 at Piper Sandler; 'Lowering PT But Staying Bullish'
Tweet Send to a Friend
Piper Sandler analyst David Amsellem lowered the price target on Avadel Pharmaceuticals (NASDAQ: AVDL) to $13.00 (from $24.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
